Form 4: Guardant Health Director Meghan V. Joyce Reports Stock Transactions
SEC Form 4 Filing
Director Meghan V. Joyce of Guardant Health, Inc. reports the acquisition of 66 shares of common stock on July 4, 2024, through the vesting of restricted stock units.
Summary
- On July 4, 2024, Meghan V. Joyce, a director of Guardant Health, Inc., acquired 66 shares of common stock.
- This acquisition was a result of the vesting of restricted stock units.
- The price per share was $0.
- Following the transaction, Joyce directly owns 10,279 shares of Guardant Health common stock and 863 restricted stock units.
Sentiment
Score: 5
Explanation: This is a neutral report of stock transactions. It doesn't inherently indicate positive or negative sentiment about the company's performance.
Industry Context
This filing is a routine disclosure of stock transactions by a company insider, as required by the SEC. It provides transparency to the market regarding the actions of company directors.
Stakeholder Impact
- The transaction has a minimal impact on shareholders, as it involves a small number of shares acquired through existing compensation plans.
Key Dates
| Date | Description |
|---|---|
| August 4, 2022 | 25% of the restricted stock units vested. |
| July 4, 2024 | Date of transaction: acquisition of 66 shares of common stock through vesting of restricted stock units. |
| July 5, 2024 | Date of signature for the report. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.